For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Goodfellow gems #107
Wednesday 31 July 2019, 03:00 AM

“Stop using Augmentin. Bring back the Augmentin-free office”
The only first-line indications for Augmentin (amoxicillin/clavulanic acid) are human/ animal bites or diabetic foot ulcers (with cellulitis), yet the
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References
1. Health Quality & Safety Commission
2. BPACnz 2017
3. BPACnz 2007